Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Alcon: 3 Key Takeaways for Long-Term Investors
Alcon Inc. (ALC) Q3 2026 Earnings Call Transcript
ALC's Q3 Earnings Beat, Revenues Miss, '26 Outlook Narrows, Stock Down
Alcon shares fall as tighter eye-care market outlook raises growth concerns
Alcon (ALC) Reports Q3 Earnings: What Key Metrics Have to Say
Innovation and Product Launch Momentum Drive Alcon's Third-Quarter 2026 Growth
Algoma Central Corporation Announces Closing of Over-Allotment Option of Additional Debentures
Algoma Central Corporation Reports Financial Results for the 2026 Third Quarter
Countdown to Alcon (ALC) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Alcon (ALC) Surges 6.8%: Is This an Indication of Further Gains?
Higher Margins, Better ROIC And Capable Management Define Pershing Square's Q3 2026 Portfolio
Alcon Sees Another Bullish Rating After Clear Portfolio Growth Direction In Eyecare
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
Algoma Central Corporation Announces $62.5 million Offering of 6.20% Convertible Unsecured Subordinated Debentures
FDA Approves Alcon's BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
FDA Approves Alcon's BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
Credo Expands AI Connectivity Portfolio With 1.6T ZeroFlap ALC
Credo Unveils 1.6T ZeroFlap Active Light Cable, Industry's First Row-Scale, Wide-Parallel Optical Interconnect for AI Data Centers
Algoma Central (TSE:ALC) Shares Cross Above 50 Day Moving Average – Here’s Why
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Already premium?